Skip to content

Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01501448
Enrollment
118
Registered
2011-12-29
Start date
2012-01-31
Completion date
2013-02-28
Last updated
2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The recent controversy regarding the use of pill for cycle planning in GnRH antagonists IVF cycle has driven the search for new ways to plan IVF cycles in order to avoid weekends or to equally distribute the workload. Recently, mid-late luteal phase oral estrogens seem to be as good as the pill. The investigators will compare OCP vs oral estrogens to plan the initiation of IVF cycles.

Interventions

30 microgram of ethinylestradiol plus levonorgestrel daily for 12 to 16 days

DRUGEstradiol valerate

4mg estradiol valerate from cycle day 20 till the day before the initiation of the cycle

Sponsors

IVI Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

* 1st or 2nd IVF cycle * BMI \<30 kg/m2 * regular menstrual cycles * basal FSH \<10IU and E2 \<60pg/mL

Exclusion criteria

* polycystic ovaries * endometriosis * previous ovarian surgery * previous low ovarian response

Design outcomes

Primary

MeasureTime frameDescription
Implantation rate20 days after the embryo transfernumber of embryonic sacs visible by ultrasound divided by the number of embryos transferred

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026